New cancer clinical trial: First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin

Published on: April 25, 2018 at 12:00PM
Condition:   Mesothelioma, Ovarian Neoplasms
Intervention:   Drug: BAY2287411 Injection
Sponsor:   Bayer
Not yet recruiting
https://ift.tt/2HtPSy4